Christopher Patrick Marshall

Title: Christopher Patrick Marshall: Innovator in Respiratory Syncytial Virus Research

Introduction

Christopher Patrick Marshall is a notable inventor in the field of virology, particularly known for his work on respiratory syncytial virus (RSV) F proteins. His innovative approach focuses on stabilizing these proteins in their pre-fusion conformation, which is crucial for developing effective vaccines and treatments. Despite having no patents to his name, his contributions to the scientific community are significant.

Latest Patents

Marshall's work includes the invention titled "Conformationally Stabilized RSV Pre-Fusion F Proteins." This invention provides RSV F proteins, polypeptides, and protein complexes that incorporate cross-links to stabilize them in their pre-fusion state. Additionally, the invention outlines methods for creating compositions that include these proteins, which can be utilized in vaccine formulations.

Career Highlights

Throughout his career, Christopher Patrick Marshall has worked with esteemed organizations such as Calder Biosciences Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. His experience in these institutions has allowed him to contribute to significant advancements in the understanding and treatment of viral infections.

Collaborations

Marshall has collaborated with notable colleagues in his field, including Jason Scott Mclellan and Peter Joseph Alff. These partnerships have fostered a collaborative environment that enhances research and innovation in virology.

Conclusion

Christopher Patrick Marshall's work in the field of respiratory syncytial virus research exemplifies the importance of innovation in developing effective medical solutions. His contributions, although not patented, play a vital role in advancing our understanding of viral proteins and their applications in vaccine development.